{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:11:00Z","timestamp":1759482660305},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1136\/thoraxjnl-2015-207080","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T13:53:34Z","timestamp":1428933214000},"page":"401-403","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?"],"prefix":"10.1136","volume":"70","author":[{"given":"Guy G","family":"Brusselle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2015-207080-1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"key-10.1136\/thoraxjnl-2015-207080-2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"key-10.1136\/thoraxjnl-2015-207080-3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non\u2013cystic fibrosis bronchiectasis: the bat randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"key-10.1136\/thoraxjnl-2015-207080-5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2015-207080-6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/thx.52.10.915","article-title":"Erythromycin and diffuse panbronchiolitis","volume":"52","author":"Koyama","year":"1997","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2015-207080-7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases","volume":"33","author":"Crosbie","year":"2009","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207080-8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MCP.0000000000000017","article-title":"Is there a role for macrolides in severe asthma?","volume":"20","author":"Brusselle","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.coph.2008.01.010","article-title":"Macrolides as immunomodulatory medications for the therapy of chronic lung diseases","volume":"8","author":"Lopez-Boado","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"key-10.1136\/thoraxjnl-2015-207080-10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respir Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-11","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2014-205998","article-title":"A randomised controlled trial of azithromycin therapy in Bronchiolitis Obliterans Syndrome (BOS) post lung transplantation","author":"Corris","year":"2015","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2015-207080-12","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2014-206067","article-title":"Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma","author":"Essilfie","year":"2015","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2015-207080-13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207080-14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200212-1424BC","article-title":"Maintenance azithromycin therapy for bronchiolitis obliterans syndrome","volume":"168","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200411-1537OC","article-title":"Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome","volume":"172","author":"Yates","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.healun.2009.12.003","article-title":"Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome","volume":"29","author":"Jain","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"key-10.1136\/thoraxjnl-2015-207080-17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207080-18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","article-title":"Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome","volume":"174","author":"Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.00134307","article-title":"A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy","volume":"32","author":"Vanaudenaerde","year":"2008","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207080-20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"key-10.1136\/thoraxjnl-2015-207080-21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207080-22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2015-207080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T05:51:16Z","timestamp":1601099476000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2015-207080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,13]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,4,13]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1136\/thoraxjnl-2015-207080"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207080","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,13]]}}}